07/17/2025
6:54 PM | BlackRock, Inc. (Filed by)
Day One Biopharmaceuticals (Subject)
| Form SCHEDULE 13G | |
06/18/2025
6:41 PM | Day One Biopharmaceuticals (Issuer)
VASCONCELLES MICHAEL (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/18/2025
6:42 PM | Day One Biopharmaceuticals (Issuer)
VASCONCELLES MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
4:47 PM | Day One Biopharmaceuticals (Issuer)
Josey John A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
4:47 PM | Day One Biopharmaceuticals (Issuer)
Holles Natalie C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
4:49 PM | Day One Biopharmaceuticals (Issuer)
Nicholson Garry A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
4:50 PM | Day One Biopharmaceuticals (Issuer)
Garland J. Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
4:51 PM | Day One Biopharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
4:53 PM | Dable Habib J (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
4:54 PM | Day One Biopharmaceuticals (Issuer)
Grossman William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:44 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for DAWN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Day One Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
05/19/2025
4:45 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:48 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:54 PM | Day One Biopharmaceuticals (Issuer)
Merendino Lauren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2025
4:45 PM | BlackRock, Inc. (Filed by)
Day One Biopharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/11/2025
3:01 PM | Day One Biopharmaceuticals (Filer)
| Form DEF 14A | |
04/11/2025
3:03 PM | Day One Biopharmaceuticals (Filer)
| Form DEFA14A | |
04/11/2025
3:06 PM | Day One Biopharmaceuticals (Filer)
| Form ARS | |
03/06/2025
4:02 PM | Day One Biopharmaceuticals (Filer)
| Form 10-K/A | |
02/28/2025
6:50 PM | Day One Biopharmaceuticals (Issuer)
Merendino Lauren (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/21/2025
5:05 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:08 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:10 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
5:02 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
5:04 PM | Day One Biopharmaceuticals (Subject)
York Charles N II (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
5:07 PM | Day One Biopharmaceuticals (Subject)
Dubow Adam (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
5:31 PM | Day One Biopharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025
8:28 AM | Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
01/31/2025
3:33 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
3:36 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
3:38 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
7:07 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
3:21 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
3:22 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
3:15 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
8:24 AM | Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/07/2024
8:12 AM | Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
11/04/2024
4:24 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:48 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:53 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:59 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Critical AI announcement set to ignite AI 2.0 (Ad) I just put together an urgent new presentation that you need to see right away.
In short: I believe we are mere days away from a critical announcement from a key tech leader…
One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.  Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
08/19/2024
5:07 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
5:12 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
4:17 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
4:23 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
6:35 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
6:04 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
